Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Linch

Showing results (301-310 of 304) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 304 results.
British Journal of Cancer|July 1, 1996
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation reportD C Linch, B Vaughan Hudson, B W Hancock, et al.
British Journal of Cancer|May 9, 2013
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsR Cooke, M E Jones, D Cunningham, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Blood|September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Pageof 31

Showing results (301-310 of 304) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 304 results.
British Journal of Cancer|July 1, 1996
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation reportD C Linch, B Vaughan Hudson, B W Hancock, et al.
British Journal of Cancer|May 9, 2013
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsR Cooke, M E Jones, D Cunningham, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Blood|September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Pageof 31